Analyst Ratings for Upstream Bio (UPB)
UPB Rating Summary
UPB Price Target Summary
- Highest: $75.00 (Piper Sandler)
- Lowest: $8.00 (JPMorgan)
- Average: $38.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.57 (+450.2%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
Avg. $ Target:
$38.57 (+450.2%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/12/2026 | JPMorgan | Tessa Romero | Downgrade | Neutral (Overweight) |
8.00 (35.00) |
6.28 (7.01) |
11.62% | Details |
| 6/3/2026 | H.C. Wainwright | Matthew Caufield | New Coverage | Buy (N/A) |
36.00 (N/A) |
7.25 (7.01) |
-3.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
